Analyst Jan Wald is focused on the Healthcare sector with 15 price targets and ratings documented since 2013 spanning on 1 stocks. Previously, Jan Wald worked at BENCHMARK. Analyst's average stock valuation to be materialised ratio is 100% with an average time for price targets to be met of 367 days.
Most recent stock forecast was given on EXAS, Exact Sciences Corporation at 26-Oct-2016.
Jan Wald best performing recommendations are on EXAS (EXACT SCIENCES CORPORATION).
The best stock recommendation documented was for EXAS (EXACT SCIENCES CORPORATION) at 2/24/2016. The price target of $9 was fulfilled within 111 days with a profit of $3.13 (53.32%) receiving and performance score of 4.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
60
11 days ago
1/7 (14.29%)
$29.74 (48.24%)
63
Buy
75
$7.52 (11.14%)
95
17 days ago
18/27 (66.67%)
$22.99 (32.07%)
140
Buy
70
$2.52 (3.73%)
120
1 months 13 days ago
17/18 (94.44%)
$10.71 (20.26%)
110
Buy
65
$-2.48 (-3.68%)
85
1 months 13 days ago
7/8 (87.5%)
$10.8 (16.74%)
62
Hold
50
$-17.48 (-25.90%)
40
2 months 15 days ago
3/3 (100%)
$2.69 (5.95%)
84
